| UniProt ID | TMCC1_HUMAN | |
|---|---|---|
| UniProt AC | O94876 | |
| Protein Name | Transmembrane and coiled-coil domains protein 1 | |
| Gene Name | TMCC1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 653 | |
| Subcellular Localization |
Endoplasmic reticulum membrane Multi-pass membrane protein . |
|
| Protein Description | ||
| Protein Sequence | MEPSGSEQLFEDPDPGGKSQDAEARKQTESEQKLSKMTHNALENINVIGQGLKHLFQHQRRRSSVSPHDVQQIQADPEPEMDLESQNACAEIDGVPTHPTALNRVLQQIRVPPKMKRGTSLHSRRGKPEAPKGSPQINRKSGQEMTAVMQSGRPRSSSTTDAPTSSAMMEIACAAAAAAAACLPGEEGTAERIERLEVSSLAQTSSAVASSTDGSIHTDSVDGTPDPQRTKAAIAHLQQKILKLTEQIKIAQTARDDNVAEYLKLANSADKQQAARIKQVFEKKNQKSAQTILQLQKKLEHYHRKLREVEQNGIPRQPKDVFRDMHQGLKDVGAKVTGFSEGVVDSVKGGFSSFSQATHSAAGAVVSKPREIASLIRNKFGSADNIPNLKDSLEEGQVDDAGKALGVISNFQSSPKYGSEEDCSSATSGSVGANSTTGGIAVGASSSKTNTLDMQSSGFDALLHEIQEIRETQARLEESFETLKEHYQRDYSLIMQTLQEERYRCERLEEQLNDLTELHQNEILNLKQELASMEEKIAYQSYERARDIQEALEACQTRISKMELQQQQQQVVQLEGLENATARNLLGKLINILLAVMAVLLVFVSTVANCVVPLMKTRNRTFSTLFLVVFIAFLWKHWDALFSYVERFFSSPR | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Acetylation | -------MEPSGSEQ -------CCCCCCCC | 18.03 | 22814378 | |
| 6 (in isoform 2) | Phosphorylation | - | 26.89 | 30266825 | |
| 63 | Phosphorylation | FQHQRRRSSVSPHDV HHHHHHHCCCCHHHH | 33.03 | 22817900 | |
| 64 | Phosphorylation | QHQRRRSSVSPHDVQ HHHHHHCCCCHHHHH | 25.46 | 22817900 | |
| 66 | Phosphorylation | QRRRSSVSPHDVQQI HHHHCCCCHHHHHHH | 20.61 | 26471730 | |
| 117 | Methylation | RVPPKMKRGTSLHSR CCCCCCCCCCCCCCC | 50.56 | 115918605 | |
| 120 | Phosphorylation | PKMKRGTSLHSRRGK CCCCCCCCCCCCCCC | 27.23 | 26437602 | |
| 134 | Phosphorylation | KPEAPKGSPQINRKS CCCCCCCCCCCCCCC | 21.54 | 21955146 | |
| 140 | Acetylation | GSPQINRKSGQEMTA CCCCCCCCCCCCCHH | 55.22 | 7670837 | |
| 141 | Phosphorylation | SPQINRKSGQEMTAV CCCCCCCCCCCCHHH | 42.33 | 28555341 | |
| 156 | Phosphorylation | MQSGRPRSSSTTDAP HHCCCCCCCCCCCCC | 31.18 | 22817900 | |
| 157 | Phosphorylation | QSGRPRSSSTTDAPT HCCCCCCCCCCCCCC | 32.74 | 22817900 | |
| 158 | Phosphorylation | SGRPRSSSTTDAPTS CCCCCCCCCCCCCCC | 36.25 | 20736484 | |
| 159 | Phosphorylation | GRPRSSSTTDAPTSS CCCCCCCCCCCCCCH | 30.55 | 20736484 | |
| 160 | Phosphorylation | RPRSSSTTDAPTSSA CCCCCCCCCCCCCHH | 31.92 | 20736484 | |
| 212 | Phosphorylation | SSAVASSTDGSIHTD CCHHHCCCCCCCCCC | 41.71 | 24532841 | |
| 215 | Phosphorylation | VASSTDGSIHTDSVD HHCCCCCCCCCCCCC | 17.63 | 24532841 | |
| 253 | Phosphorylation | EQIKIAQTARDDNVA HHHHHHHHCCCCCHH | 18.03 | - | |
| 337 | Phosphorylation | KDVGAKVTGFSEGVV HHHCCCCCCCCCCHH | 31.63 | - | |
| 348 | Acetylation | EGVVDSVKGGFSSFS CCHHHHHCCCCCCHH | 58.21 | 7704131 | |
| 353 | Phosphorylation | SVKGGFSSFSQATHS HHCCCCCCHHHHHHC | 27.02 | 28857561 | |
| 374 | Phosphorylation | SKPREIASLIRNKFG CCHHHHHHHHHHHHC | 29.95 | 24719451 | |
| 382 | Ubiquitination | LIRNKFGSADNIPNL HHHHHHCCCCCCCCH | 35.27 | 21906983 | |
| 382 | Phosphorylation | LIRNKFGSADNIPNL HHHHHHCCCCCCCCH | 35.27 | 19664994 | |
| 392 | Phosphorylation | NIPNLKDSLEEGQVD CCCCHHHHHHHCCCC | 35.77 | 30266825 | |
| 409 | Phosphorylation | GKALGVISNFQSSPK HHHHHHHHCCCCCCC | 29.23 | 28102081 | |
| 413 | Phosphorylation | GVISNFQSSPKYGSE HHHHCCCCCCCCCCH | 44.46 | 30266825 | |
| 414 | Phosphorylation | VISNFQSSPKYGSEE HHHCCCCCCCCCCHH | 18.03 | 19664994 | |
| 417 | Phosphorylation | NFQSSPKYGSEEDCS CCCCCCCCCCHHHHC | 29.30 | 21406692 | |
| 419 | Phosphorylation | QSSPKYGSEEDCSSA CCCCCCCCHHHHCCC | 34.42 | 21406692 | |
| 424 | Phosphorylation | YGSEEDCSSATSGSV CCCHHHHCCCCCCCC | 35.02 | 21406692 | |
| 425 | Phosphorylation | GSEEDCSSATSGSVG CCHHHHCCCCCCCCC | 41.73 | 21406692 | |
| 427 | Phosphorylation | EEDCSSATSGSVGAN HHHHCCCCCCCCCCC | 35.25 | 21406692 | |
| 428 | Phosphorylation | EDCSSATSGSVGANS HHHCCCCCCCCCCCC | 28.87 | 21406692 | |
| 430 | Phosphorylation | CSSATSGSVGANSTT HCCCCCCCCCCCCCC | 19.69 | 21406692 | |
| 435 | Phosphorylation | SGSVGANSTTGGIAV CCCCCCCCCCCCEEE | 27.15 | 21406692 | |
| 436 | Phosphorylation | GSVGANSTTGGIAVG CCCCCCCCCCCEEEC | 29.30 | 21406692 | |
| 437 | Phosphorylation | SVGANSTTGGIAVGA CCCCCCCCCCEEECC | 32.98 | 21406692 | |
| 445 | Phosphorylation | GGIAVGASSSKTNTL CCEEECCCCCCCCCC | 29.26 | 21406692 | |
| 446 | Phosphorylation | GIAVGASSSKTNTLD CEEECCCCCCCCCCC | 35.01 | 21406692 | |
| 447 | Phosphorylation | IAVGASSSKTNTLDM EEECCCCCCCCCCCC | 40.79 | 21406692 | |
| 449 | Phosphorylation | VGASSSKTNTLDMQS ECCCCCCCCCCCCHH | 35.07 | 27732954 | |
| 451 | Phosphorylation | ASSSKTNTLDMQSSG CCCCCCCCCCCHHHH | 29.39 | 27732954 | |
| 479 | Phosphorylation | TQARLEESFETLKEH HHHHHHHHHHHHHHH | 21.00 | 21815630 | |
| 482 | Phosphorylation | RLEESFETLKEHYQR HHHHHHHHHHHHHHH | 40.91 | 29523821 | |
| 539 | Phosphorylation | SMEEKIAYQSYERAR HHHHHHHHHHHHHHH | 11.06 | 26657352 | |
| 542 | Phosphorylation | EKIAYQSYERARDIQ HHHHHHHHHHHHHHH | 8.23 | 26657352 | |
| 561 | Ubiquitination | ACQTRISKMELQQQQ HHHHHHHHHHHHHHH | 33.74 | 2190698 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TMCC1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TMCC1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TMCC1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
Oops, there are no PPI records of TMCC1_HUMAN !! | ||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-414, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-382, AND MASSSPECTROMETRY. | |